title: [Grading of astrocytomas and oligodendrogliomas].
abstract: The histologic determination of the degree of tissue anaplasia and grade of malignancy of gliomas is based upon qualitative histological features (nuclear pleomorphism, mitoses, endothelial proliferation, tumor necrosis). This grading approach is influenced by the subjective interpretation of the pathologist, especially concerning the weighting of criteria (scant, moderate, pronounced). An observer-independent approach seems to be feasible by abandoning the concept of parameter weighting in favor of an binary approach noting only the presence or absence of these structure parameters. This grading procedure is recognized in the revised WHO classification of brain tumors for common type astrocytomas (Ste. Anne-Mayo System, SAMS). Our results indicate that a similar approach is also suitable for grading purposes of oligodendrogliomas and mixed gliomas. Our recent investigations on glioma grading showed, both for astrocytomas and oligodendrogliomas, that a two-tiered grading scheme distinguishing only "low-grade" and "high grade" cases was prognostically relevant. For all glioma entities the onset of tumor angiogenesis with endothelial proliferation and contrast enhancement in CT and MRI seems to be the key criterion indicating irreversible tumor progression to the "high" malignancy grade.
authors.affiliation: Abteilung für Neuropathologie, Universitätskliniken des Saarlandes, Homburg/Saar.
authors.forename: H
authors.initials: H
authors.lastname: Kolles
authors.forename: I
authors.initials: I
authors.lastname: Niedermayer
authors.forename: W
authors.initials: W
authors.lastname: Feiden
mesh_terms: D001254:Astrocytoma / Q000145:classification / Q000401:mortality / Q000473:pathology*; D001921:Brain / Q000473:pathology; D001932:Brain Neoplasms / Q000145:classification / Q000401:mortality / Q000473:pathology*; D005909:Glioblastoma / Q000145:classification / Q000401:mortality / Q000473:pathology*; D005910:Glioma / Q000145:classification / Q000401:mortality / Q000473:pathology; D006801:Humans; D009837:Oligodendroglioma / Q000145:classification / Q000401:mortality / Q000473:pathology*; D011379:Prognosis; D015203:Reproducibility of Results; D016019:Survival Analysis